Anti-CD5 monoclonal antibody
Alternative Names: Anti-Leu1Latest Information Update: 13 Feb 2007
Price :
$50 *
At a glance
- Originator Becton, Dickinson and Company
- Class Immunotherapies; Monoclonal antibodies
- Mechanism of Action CD5 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Graft-versus-host disease